Bone Marrow Transplantation in Children with Hunter Syndrome: Outcome after 7 to 17 Years

Journal of Pediatrics

Volumn 154, Issue 5, 2009, Pages 733-737

  Guffon, Nathalie ^a   Bertrand, Yves ^a   Forest, Isabelle ^a   Fouilhoux, Alain ^a   Froissart, Roseline ^a  

^a HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; METHOTREXATE; PENICILLIN G; THYMOCYTE ANTIBODY;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; ENGRAFTMENT; FOLLOW UP; GRAFT INFECTION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEARING IMPAIRMENT; HEPATOSPLENOMEGALY; HLA MATCHING; HUMAN; HUNTER SYNDROME; INTELLIGENCE QUOTIENT; JOINT STIFFNESS; KYPHOSIS; MALE; NEUROPSYCHOLOGICAL TEST; NEUTROPHIL COUNT; ORGAN DONOR; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIBLING;

ADOLESCENT; BODY HEIGHT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GLYCOSAMINOGLYCANS; GRAFT SURVIVAL; HEART VALVES; HEPATOMEGALY; HUMANS; IDURONATE SULFATASE; INTELLIGENCE TESTS; JOINT DISEASES; LEUKOCYTES; MALE; MOBILITY LIMITATION; MUCOPOLYSACCHARIDOSIS II; OUTCOME ASSESSMENT (HEALTH CARE); SOCIAL ADJUSTMENT; SPLENOMEGALY; TISSUE DONORS;

EID: 64549141555     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.11.041     Document Type: Article

References (17)

1. Wraith J.E., Scarpa M., Beck M., et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 167 (2008) 267-277
2. Baehner F., Schmiedeskamp C., Krummenauer F., et al. Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 28 (2005) 1011-1017
3. Poorthuis B.J., Wevers R.A., Kleijer W.J., et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 105 (1999) 151-156
4. Muenzer J., Gucsavas-Calikoglu M., McCandless S.E., Schuetz T.J., and Kimura A. A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Mol Genet Metab 90 (2007) 329-337
5. Muenzer J., Wraith J.E., Beck M., et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med 8 (2006) 465-473
6. Zareba G. Idursulfase in Hunter syndrome treatment. Drugs Today (Barc) 43 (2007) 759-767
7. Guffon N., Souillet G., Maire I., Straczek J., and Guibaud P. Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 133 (1998) 119-125
8. Souillet G., Guffon N., Maire I., et al. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant 31 (2003) 1105-1117
9. Peters C., Balthazor M., Shapiro E.G., et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 87 (1996) 4894-4902
10. Hobbs J. The evolution of displacement bone marrow transplantation for inborn errors. In: Hobbs J. (Ed). Correction of Certain Genetic Diseases by Transplantation (1989), The COGENT Fund, London 1-22
11. Hall C.W., and Neufeld E.F. Alpha-L-iduronidase activity in cultured skin fibroblasts and amniotic fluid cells. Arch Biochem Biophys 158 (1973) 817-821
12. Piraud M., Boyer S., Mathieu M., and Maire I. Diagnosis of mucopolysaccharidoses in a clinically selected population by urinary glycosaminoglycan analysis: a study of 2,000 urine samples. Clin Chim Acta 221 (1993) 171-181
13. Young E.P. Prenatal diagnosis of Hurler disease by analysis of alpha-iduronidase in chorionic villi. J Inherit Metab Dis 15 (1992) 224-230
14. Wong Z., Wilson V., Patel I., Povey S., and Jeffreys A.J. Characterization of a panel of highly variable minisatellites cloned from human DNA. Ann Hum Genet 51 (1987) 269-288
15. Vellodi A., Young E., Cooper A., Lidchi V., Winchester B., and Wraith J.E. Long-term follow-up following bone marrow transplantation for Hunter disease. J Inherit Metab Dis 22 (1999) 638-648
16. Mullen C.A., Thompson J.N., Richard L.A., and Chan K.W. Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia. BMT 25 (2000) 1093-1099
17. Wraith J.E., Scarpa M., Beck M., Bodamer O.A., De Meirleir L., Guffon N., et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 167 (2008) 267-277